Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 4, Status: Authorised
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 11, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Pirsue, pirlimycin, Date of authorisation: 29/01/2001, Status: Withdrawn
Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin,metformin hydrochloride, Date of authorisation: 23/03/2018, Revision: 9, Status: Authorised
Agenda of the HMPC meeting 5-7 May 2025
The Foundation for the Development of Internal Medicine in Europe (FDIME) announces the of a new grant for EFIM Young Internists.
The funding is intended for research projects dedicated to AI applications in Internal Medicine.
A 10,000 Euros grant will be awarded.
Young internists (up to the age of 40 years) from EFIM member countries are the target audience.
The eligibility criteria must be met as stated in the Announcements.
Applicants are required to submit their own Research Project proposal.
Human medicines European public assessment report (EPAR): Lyrica, pregabalin, Date of authorisation: 05/07/2004, Revision: 70, Status: Authorised
The Foundation for the Development of Internal Medicine in Europe (FDIME) is offering Research Grants to Young Internists (up to age 38 yrs) to study in Research projects including all fields of General Internal Medicine, particularly polymorbidity and other common Internal Medicine conditions.
Up to 17,500 Euros is available, to be awarded for a maximum study period of 1 year.
Deadline for Receipt of Applications: 30 June 2025
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Date of authorisation: 27/07/2020, Revision: 16, Status: Authorised